Home › Upcoming votes › Palomino Laboratories Inc.
This meeting took place on November 5, 2026. Palomino Laboratories Inc. reported the official results on Form 8-K, filed November 6, 2026 (read it on EDGAR); they are listed below.
The deadline as the proxy statement states it: “Voting will be open until 11:59 p.m. (EST) on November 4, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot: see the proxy statement. The items on this ballot could not be read from the filing with enough confidence to list them here. Read the proxy statement.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Jeffrey B. Shealy | 100% | — |
| Elect Director: Steven P. DenBaars | 100% | Elected |
| Elect Director: Richard Ogawa | 100% | Elected |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.